Abstract
Acute doxorubicin-loaded nanoparticle (DXNP) renal toxicity was explored in both normal rats and rats with experimental glomerulo-nephritis. In normal rats, 2/6 rats given free doxorubicin (DX) (5 mg / kg) died within one week, whereas all control animals and all rats having received free NP or DXNP survived. A 3 times higher proteinuria appeared in animals treated with DXNP than in those treated with DX. Free NP did not provoke any proteinuria. Two hr post-injection, DXNP was 2.7 times more concentrated in kidneys than free DX (p<0.025). In rats with immune experimental glomerulonephritis, 5/6 rats given DX died within 7 days, in contrast to animals treated by DXNP, NP, or untreated, which all survived. Proteinuria appeared in all series, but was 2-5 times more intense (p>0.001) and prolonged after doxorubicin treatment (400-700 mg / day), without significant difference between DXNP and DX. Rats treated by unloaded NP behaved as controls. These results demonstrate that, in these experimental conditions, DXNP killed less animals than free DX, despite of an enhanced renal toxicity of the former. Both effects (better survival and nephrosis) are most probably related to an enhanced capture of DXNP by cells of the mono-nuclear phagocyte system, including mesangial cells.
Similar content being viewed by others
REFERENCES
P. Couvreur, B. Kante, M. Roland and P. Speiser. Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release characteristics in a calf serum medium. J. Pharm. Sci. 68:1521–24 (1979a).
P. Couvreur, B. Kante, M. Roland, P. Guiot, P. Baudhuin and P. Speiser. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31: 331–332 (1979b).
P. Couvreur, B. Kante, L. Grislain, M. Roland and P. Speiser. Toxicity of polyalkylcyanoacrylate nanoparticles. II: Doxorubicin-loaded nanoparticles. J. Pharm. Sci. 71: 790–792 (1982).
P. Couvreur, L. Roblot-Treupel, M. F. Poupon, F. Brasseur and F. Puisieux, Nanoparticles as microcarriers for anticancer drugs. Adv. Drug Deliv. Rev. 5:209–230 (1990).
P. Couvreur and C. Vauthier. Polyalkylcyanoacrylate as drug carrier: present state and perspectives. J. Control. Rel. 17:187–188 (1991).
N. Chiannilkulchai, N. Ammoury, B. Caillou, J. P. Devissaguet and P. Couvreur. Hepatic tissue distribution of doxorubicinloaded nanoparticles after i.v. administration in reticulosarcoma M5076 metastases-bearing mice. Cancer Chemother. Pharmacol. 26:122–126 (1990).
C. Cuvier, L. Roblot-Treupel, S. Chevillard, J. M. Millot, M. Manfait, G. Bastian, P. Couvreur and M. F. Poupon. Doxorubicin-loaded nanospheres bypass tumour cell multidrug resistance. Biochim. Pharmacol. 44:509–517 (1992).
L. Manil, J. C. Davin, C. Dechenne, C. Kubiak, J. Foidart, P. Couvreur, P. Mahieu. Uptake of nanoparticles by rat glomerular mesangial cells in vitro and in vivo. Pharm. Res. 11:(8):1160–1165 (1994).
S. Okuda, Y. Oh, H. Tsuruda, K. Onoyama, S. Fujimi and M. Fujishima. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int. 29:502–510 (1986).
G. T. Schreiner, R. S. Cotran, V. Pardo and E. R. Unanue. A mononuclear cell component in experimental immunological glomerulonephritis. J. Exp. Med. 147:369–384 (1978).
F. B. Kingsbury and C. P. Clarck. The rapid determination of albumin in urine. J. Lab. Clin. Med 11:981–986 (1926).
O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–272 (1951).
T. Bertani, F. Cutillo, C. Zoja, M. Broggini, G. Remuzzi. Tubulo-interstitial lesions mediate damage in adriamycin glomerulopathy. Kidney Int. 30:488–496 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Manil, L., Mahieu, P. & Couvreur, P. Acute Renal Toxicity of Doxorubicin (Adriamycin)-Loaded Cyanoacrylate Nanoparticles. Pharm Res 12, 85–87 (1995). https://doi.org/10.1023/A:1016290704772
Issue Date:
DOI: https://doi.org/10.1023/A:1016290704772